Company Categories: Antibodies, Assays, Drug Development, Drug Discovery, Enzymes and Recombinant Proteins
High-quality Bioreagents for Pharma and Drug Discovery Research
DetailsStressMarq Biosciences is a global bioreagents company that produces high-quality, innovative antibodies, proteins, assay kits, and small molecules for the life sciences, pharma and drug discovery research markets.
Innovative Bioreagents for Neurodegenerative Disease Research
With innovative bioreagents for neurodegenerative disease research, StressMarq is a pioneer and market leader in the development and commercialization of a range of fibrilized and oligomeric protein preparations for use in neurodegenerative disease research, including alpha synuclein, tau, amyloid beta, SOD1 and TTR.
StressMarq is strategically focused on expanding the breadth and depth of this product offering through the development of additional fibrilized proteins, oligomers, and related antibodies to assist researchers studying Alzheimer’s, Parkinson’s, and other neurodegenerative diseases.
Antibodies, Proteins, Immunoassay Kits, and Small Molecules
With a diverse portfolio of antibodies, proteins, immunoassay kits, and small molecules, StressMarq offers comprehensive solutions and tools that bridge across a multitude of life sciences fields including neuroscience, cancer research, oxidative stress, and cell signaling.
The company’s goal is to be a world leader in the development and supply of active, pathology-inducing protein aggregates to assist scientists with disease model development and accelerate neurodegenerative disease drug discovery. StressMarq’s products are available internationally through an extensive network of distributors in over 45 countries.
Fibrillar and Oligomeric Proteins for Neuroscience Research
Investigating the accumulation of protein aggregates has emerged as a pivotal area of neurodegenerative disease research. Specifically, abnormal aggregates of alpha synuclein, tau and amyloid beta are hallmarks of neurodegenerative disease pathology.
StressMarq’s unique pre-formed fibrils, oligomers and monomers have proven instrumental in aiding researchers working on the development of disease models and testing of potential drug candidates for combating these diseases.
Alpha Synuclein, Tau, and Amyloid Beta
StressMarq’s fibrillar and oligomeric proteins can induce toxicity and pathology in research models. For example, alpha synuclein pre-formed fibrils seed the formation of new fibrils and have been used to induce endogenous alpha synuclein phosphorylation and subsequent Lewy body inclusion formation in neuronal cell culture and can also be used for in vitro oligomerization studies. Further, the implicit process of tau aggregation has been demonstrated with StressMarq’s tau pre-formed fibrils, which recruit tau monomers to form larger tau fibrils, and have been shown to induce tau pathology in vivo. Similarly, StressMarq’s amyloid beta oligomers and pre-formed fibrils can induce toxicity in primary rat cortical neurons.
StressMarq manufactures a large breadth and depth of constructs for these proteins, including a variety of species, mutations, isoforms, expression systems, and phosphorylation sites to provide researchers with the optimal product for their niche research.
Antibodies as Research Tools
StressMarq is proud to offer an extensive selection of highly validated antibodies. These products are the historic backbone of the company, with targets relevant to a wide range of fields in life sciences, pharmaceutical and drug discovery research.
In the neurodegenerative disease space, StressMarq has manufactured numerous antibodies to target pertinent proteins, including phospho-tau and phospho-alpha synuclein antibodies.
Customized Products and Support Services
StressMarq strives to support customers and their individual experiments. StressMarq aims to provide the best customer experience, from providing information to aid in purchasing decisions, ensuring prompt order processing, delivering knowledgeable technical support, to catering to customized product requests. Due to the evolving nature of science, the company continues to work towards expanding the product portfolio through ongoing research and development and maintaining expertise in the field.
ISO 9001:2015 Certification
StressMarq Biosciences provides the highest level of product quality, starting from development through to the sales and support stages of the business. This quality standard is adhered to through system standardization and process controls including compliance with applicable regulatory requirements along with a commitment to ensure customer satisfaction.
This equates to continually improving operational efficiencies, managing risk, having a strong customer focus, and enhancing long-term sustainability and profitability within the organization.
StressMarq is committed to quality and a continual effort to support researchers around the world with high-quality antibodies, proteins, small molecules, and assay kits. ISO 9001:2015 certified with URS, StressMarq strives to maintain the highest standard every day to uphold this certification.
Outstanding Sustainability Performance
StressMarq was recently awarded a medal from EcoVadis, the world’s most trusted provider of business sustainability ratings. This independent assessor evaluates companies’ policies and performance in four categories: environment, labor & human rights, ethics, and sustainable procurement. Proud to be amongst the top 50% of companies in the industry, StressMarq is dedicated to making continuous improvements in integrating sustainability within the company.
About StressMarq
Founded in 2007, StressMarq Biosciences primarily started as an antibody-based company with a small but dedicated group of scientists spearheaded by CEO and President, Dr. Ariel Louwrier. Over the past decade and a half, the company has undergone remarkable growth and expansion by consistently delivering high-quality products while prioritizing strong customer and distributor relationships.
In 2016, the company shifted its strategic focus to commercializing a variety of fibrilized proteins and asserting itself as a market leader in the neurodegenerative disease research space. This strategic decision has paved the way for continued success as StressMarq collaborates with key thought leaders and expands its global distributor network.
Through its unwavering commitment to excellence and proactive engagement with industry experts, StressMarq is recognized as a trusted partner in the life sciences, pharmaceutical research, and scientific community around the world.
ProductsParkinson’s Disease Research Products
StressMarq manufactures and offers a wide range of products specifically developed to accelerate Parkinson’s disease research. StressMarq’s cutting-edge product range includes monoclonal antibodies, polyclonal antibodies, …
Read MoreAlzheimer’s Disease Research Products
StressMarq manufactures and offers a comprehensive range of Alzheimer’s Disease Research Products. StressMarq’s product range includes Antibodies, Proteins, Immunoassays, Small Molecule Inhibitors, and unique cutting-edge …
Read MoreAmyloid Beta for Neurodegenerative Disease Research
StressMarq provides a cutting-edge selection of Amyloid Beta Pre-formed Fibrils (PFFs), Oligomers, and Monomers specifically designed to facilitate advanced neurodegenerative disease research. Monomeric Amyloid Beta …
Read MoreSOD1 for Neurodegenerative Disease Research
StressMarq has developed unique Superoxide Dismutase 1 (SOD1) Pre-formed Fibrils (PFFs) and monomers for neurodegenerative disease research, particularly valuable for researchers in understanding the role …
Read MoreTransthyretin (TTR) for Neurodegenerative Disease Research
StressMarq has developed unique Transthyretin (TTR) Filaments and Monomers designed to propel research on TTR and its association with amyloid diseases. TTR Filaments and Monomers …
Read MoreAlpha Synuclein Constructs for Neurodegenerative Disease Research
StressMarq has developed unique alpha synuclein constructs to provide invaluable support to researchers engaged in disease model development and the advancement of neurodegenerative disease research …
Read MoreTau Proteins for Neuroscience Research
StressMarq is a pioneer in the development of tau proteins that facilitate the investigation of tau aggregation, a key characteristic of neurodegenerative diseases like Alzheimer’s …
Read MoreDownloadsSonification of Pre-formed Fibrils for Neurodegenerative Disease Research
Sonification: What, Why, How and Best Practices A StressMarq Biosciences .pdf White Paper Neurodegenerative Disease Research As populations age, the prevalence of incurable neurodegenerative disease …
DownloadNeuroscience Research – Free E-Book
Neuroscience is an interdisciplinary science devoted to the study of the nervous system’s structure and function. A StressMarq Biosciences .pdf E-Book Neuroscience Research Neurodegenerative diseases …
DownloadVideosParkinson’s Disease Modelling with Alpha Synuclein Pre-Formed Fibrils and Oligomers – Video
Parkinson’s Disease is characterized by the aggregation of alpha-synuclein, a key pathological feature. In this informative video, the mechanism underlying this aggregation …
Watch VideoModelling of Neurodegenerative Diseases with Tau Pre-Formed Fibrils – Video
Tau is a key protein implicated in neurodegenerative diseases, such as Alzheimer’s and dementia. Tau Pre-formed Fibrils (PFFs) for Modelling of Neurodegenerative …
Watch VideoPress ReleasesThe Role of Tau Aggregation in Alzheimer’s Disease Pathology and Prevention
In the neurobiology landscape, the Tau protein plays a crucial role in stabilising microtubules within neurons. Positioned primarily in axons …
Read MoreAlpha-Synuclein Aggregation: A Key Target in the Battle Against Parkinson’s Disease
Parkinson’s disease (PD) is a progressive neurodegenerative condition impacting millions globally. While a blend of genetic, environmental, and ageing factors …
Read MoreInvestigating the Connections Between Amyloid Beta and Alpha Synuclein in Neurodegenerative Diseases
Alzheimer’s disease (AD) and Parkinson’s disease (PD) stand as the two most prevalent neurodegenerative disorders, each characterized by the cerebral …
Read MoreStressMarq Unveils Cutting-Edge Tau-441 (2N4R) Wild-Type Pre-formed Fibrils and Monomers (Baculovirus/Sf9)
StressMarq Biosciences, a market leader and pioneer in the field of fibrilized and oligomeric protein preparations for neurodegenerative disease research, …
Read MoreStressMarq and OrganoTherapeutics Collaborate to Further Parkinson’s Disease Research
StressMarq Biosciences, a pioneer in the development and commercialization of unique fibrilized and oligomeric protein preparations to propel the study …
Read MoreStressMarq and Gubra Generate 3D Whole-brain Imaging Model Depicting Alpha-synuclein
A collaboration between StressMarq Biosciences and Gubra has generated a 3D whole-brain light sheet fluorescence imaging model depicting alpha-synuclein pSer129+ …
Read MoreAmyloid Hypothesis vs Tau Hypothesis in Alzheimer’s Disease
In a recent scientific commentary, Brenda Knox at StressMarq delves into the complex interplay between amyloid-beta plaques and tau neurofibrillary …
Read MoreStressMarq Biosciences to Exhibit at the Neuroscience 2023 Conference
StressMarq Biosciences, a prominent leader in the field of neurodegenerative disease research products, is excited to announce its participation in …
Read MoreStressMarq Biosciences to Showcase Advanced Alzheimer’s Research Products at AAIC 2023
StressMarq Biosciences, a leading provider of cutting-edge neurodegenerative disease research products, is thrilled to announce its participation in the Alzheimer’s …
Read MoreContactStressMarq Biosciences
1537 Hillside Ave
Victoria, BC V8T 4Y2Canada
Phone: +1-250-294-9065
Email: info@stressmarq.com